Polyacrylamide (crosslinked; 2 mole percent bisacrylamide) is under investigation in clinical trial NCT00629083 (Bulking Agents for the Treatment of Stress Urinary Incontinence in Females).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.